🇺🇸 FDA

Drug profile · INN

cannabidiol

EPIDYOLEX

approved N03AX
US status
approved
Patents linked
8
News articles
0

Quick answer

cannabidiol (EPIDYOLEX) is an FDA-listed pharmaceutical active ingredient. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN cannabidiol
Brand EPIDYOLEX
Route ORAL
Formulation SOLUTION
ATC code N03AX
Originator Jazz Pharmaceuticals Ireland Limited

Related patents

Search patents →

  1. US 12396963

    Cannabidiol-type cannabinoid compound

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12383512

    Cannabidiol-type cannabinoid compound

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12364670

    Cannabidiol-type cannabinoid compound

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12357586

    Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12263139

    Use of cannabidiol in the treatment of tuberous sclerosis complex

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12226373

    Treatment of fragile X syndrome with cannabidiol

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12213951

    Treatment of autism with cannabidiol

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12186282

    Treatment of 22Q11.2 deletion syndrome with cannabidiol

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cannabidiol?

cannabidiol (EPIDYOLEX) is an FDA-listed pharmaceutical active ingredient. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for cannabidiol?

EPIDYOLEX is a marketed brand name for cannabidiol. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cannabidiol?

cannabidiol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.